journal article Apr 01, 1993

Selective digestive decontamination by erythromycin-base in a polyvalent intensive care unit

View at Publisher Save 10.1007/bf01694769
Topics

No keywords indexed for this article. Browse by subject →

References
24
[1]
Chanal CM, Sirot DL, Labia R, Petit A, Morand A, Sirot JL, Cluzel RA (1988) Comparative study of a novel plasmid-mediated β-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother 32:1660–1665 10.1128/aac.32.11.1660
[2]
De Champs C, Sirot D, Chanal C, Poupart MC, Dumas MP, Sirot J (1991) Concomitant dissemination of three extended-spectrum β-lactamases among differentEnterobacteriaceae isolated in a French hospital. J Antimicrob Chemother 27:441–457 10.1093/jac/27.4.441
[3]
De Champs C, Guelon D, Joyon D, Sirot D, Chanal M, Sirot J (1991) Treatment of a meningitis due to anEnterobacter aerogenes producing a derepressed cephalosporinase and aKlebsiella pneumoniae producing an extended-spectrum β-lactamse. Infection 19:181–183 10.1007/bf01643247
[4]
Sirot D, Sirot J, Labia R, Morand A, Courvalin P, Darfeuille-Michaud A, Perroux R, Cluzel R (1987) Transferable resistance to third-generation cephalosporins in clinical isolates ofKlebsiella pneumoniae: identification of CTX-1, a novel β-lactamase. J Antimicrob Chemother 20:323–334 10.1093/jac/20.3.323
[5]
Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents inEnterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 10:867–878 10.1093/clinids/10.4.867
[6]
Le Gall JR, Loirat P, Alperovitch A, Glaser P, Granthil C, Mathieu D, Mercier P, Thomas R, Villers D (1984) A simplified acute physiology score for ICU patients. Crit Care Med 12:975–977 10.1097/00003246-198411000-00012
[7]
Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128–140 10.1016/0196-6553(88)90053-3
[8]
Van Saene HKF, Stoutenbeek CP, Zandstra DF (1992) Eleven important definitions. Reanim Urgence 1:485–487 10.1016/s1164-6756(05)80320-2
[9]
Woolson RF (1987) Statistical methods for the analysis of biomedical data 108–110 and 215–221. Wiley, New York
[10]
Chanal C, Poupart MC, Sirot D, Labia R, Sirot J, Cluzel R (1992) Nucleotide sequences of CAZ-2, CAZ-6 and CAZ-7 β-Lactamase genes. Antimicrob Agents Chemothet 36:1817–1820 10.1128/aac.36.9.1817
[11]
Finland MC, Garner C, Wilcox C, Sabath LD (1976) Susceptibility of “enterobacteria” to penicillins, cephalosporins, lincomycins, erythromycin and rifampin. J Infect Dis 134:S75-S96 10.1093/infdis/134.supplement_1.s75
[12]
Brun-Buisson C, Legrand P, Rauss A, Richard C, Montravers F, Besbes M, Meakins JL, Soussy CJ, Lemaire F (1989) Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. Ann Intern Med 110:873–881 10.7326/0003-4819-110-11-873
[13]
Reboli AC, John Jr. JF, Levkoff AH (1989) Epidemic methicillingentamicin-resistantStaphylococcus aureus in a neonatal intensive care unit. AJDC 143:34–39
[14]
De Champs C, Sauvant MP, Chanal C, Sirot D, Gazuy N, Malhuret R, Baguet JC, Sirot J (1989) Prospective survey of colonization and infection caused by expanded-spectrum β-lactamase-producing members of the familyEnterobacteriaceae in an intensive care unit. J Clin Microbiol 27:2887–2890 10.1128/jcm.27.12.2887-2890.1989
[15]
Hartenauer U, Thulig B, Lawin P, Fegeler W (1990) Infection surveillance and selective decontamination of the digestive tract (SDD) in critically ill patients — results of a controlled study. Infection 18:22–30 10.1007/bf01644483
[16]
Godard J, Guillaume C, Reverdy ME, Bachmann P, Bui-Xuan B, Nageotte A, Motin J (1990) Intestinal decontamination in a polyvalent ICU. A double-blind study. Intensive Care Med 16:307–311 10.1007/bf01706355
[17]
Winter R, Humphreys H, Pick A, Mac Gowan AP, Willatts SM, Speller DCE (1992) A controlled trial of selective decontamination of the digestive tract in intensive care and its effect on nosocomial infection. J Antimicrob Chemother 30:73–87 10.1093/jac/30.1.73
[18]
Heizmann WR (1990) SDD and the novel extended-broad-spectrum β-lactamases. J Antimicrob Chemother 26:295–296 10.1093/jac/26.2.295
[19]
Ledingham IMcA, Alcock SR, Eastaway AT, Mc Donald JC, Mc Kay IC, Ramsay G (1988) Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care. Lancet I:785–790 10.1016/s0140-6736(88)91656-x
[20]
Andremont A, Sancho-Garnier H, Tancrede C (1986) Epidemiology of intestinal colonization by members of the familyEnterobacteriaceae highly resistant to erythromycin in a hematology-oncology unit. Antimicrob Agents Chemother 29:1104–1107 10.1128/aac.29.6.1104
[21]
Nichols RL, Condon RE, Di Santo AR (1977) Preoperative bowel preparation. Erythromycin base serum and fecal levels following oral administration. Arch Surg 112:1493–1496 10.1001/archsurg.1977.01370120083010
[22]
Andremont A, Gerbaud G, Courvalin P (1986) Plasmid-mediated high-level resistance to erythromycin inEscherichia coli. Antimicrob Agents Chemother 29:515–518 10.1128/aac.29.3.515
[23]
Vollaard EJ, Clasener HAL, Van Griethuysen AJA, Janssen AJ, Sanders-Reijmers AJ (1987) Influence of amoxycillin, erythromycin and roxithromycin on colonization resistance and on appearance of secondary colonization in healthy volunteers. J Antimicrob Chemother 20:131–138 10.1093/jac/20.suppl_b.131
[24]
De Champs C, Rouby D, Guelon D, Sirot J, Sirot D, Beytout D, Gourgand JM (1991) A case-control study of an outbreak of infections caused byKlebsiella pneumoniae strains producing CTX-1 (TEM-3) beta-lactamase. J Hosp Infect 18:5–13 10.1016/0195-6701(91)90088-p
Metrics
19
Citations
24
References
Details
Published
Apr 01, 1993
Vol/Issue
19(4)
Pages
191-196
License
View
Cite This Article
C. L. de Champs, D. P. Guelon, R. M. Garnier, et al. (1993). Selective digestive decontamination by erythromycin-base in a polyvalent intensive care unit. Intensive Care Medicine, 19(4), 191-196. https://doi.org/10.1007/bf01694769